✦ LIBER ✦

Is the incidence of cytomegalovirus disease following heart transplantation decreased by prophylactic ganciclovir and CMV-hyperimmunglobulin?

✍ Scribed by M. Cantarovich; P. René; D. Latter

Book ID: 115134408
Publisher: Springer
Year: 1994
Tongue: English
Weight: 340 KB
Volume: 7
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.1994.tb01399.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The incidence of Cytomegalovirus (CMV) a

The incidence of Cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy

✍ S. Varani; P. Spezzacatena; R. Manfredi; F. Chiodo; A. Mastroianni; P. Ballarini 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 95 KB

Retrospective review of the incidence of

Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

✍ Ashley N. Bedel; Trina S. Hemmelgarn; Rohit Kohli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Cytomegalovirus (CMV) is the most common viral infection after solid organ transplantation (SOT). Safe and effective prophylactic regimens that decrease its incidence after SOT are essential for long-term graft survival. Although valganciclovir is not Food and Drug Administration-approved for CMV pr